Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BRENTUXIMAB

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Epstein-Barr virus (EBV) is a ubiquitous herpes virus that infects the majority of the population worldwide. The virus can… Expand
  • figure 1
  • table 1
Review
2018
Review
2018
Hodgkin lymphoma (HL) is a unique hematopoietic neoplasm characterized by cancerous Reed‐Sternberg cells in an inflammatory… Expand
Highly Cited
2017
Highly Cited
2017
BACKGROUND Targeting CD30 with monoclonal antibodies in Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL) has had… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2017
2017
Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic… Expand
  • figure 1
  • figure 2
2017
2017
  • C. Scavone, L. Sportiello, +10 authors G. M. A. F. R. R. M. L. E. A. G. V. V. M. G. M. Valentini Romano Lo Schiavo Morgillo Nuzzetti D'An
  • Front. Pharmacol.
  • 2017
  • Corpus ID: 23665856
Objectives: To investigate the occurrence of adverse events (AEs) in naïve patients receiving biotech drugs. Design: A… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 4
2016
2016
Rapid identification of cytokine release syndrome after haploidentical PBSC transplantation and successful therapy with… Expand
  • figure 1
2016
2016
Monoclonal antibody therapy is a new innovation in cancer therapy. Binding of monoclonal antibodies to tumor cells facilitates… Expand
2016
2016
Acute pulmonary toxicity associated with brentuximab appears to be a rare but serious adverse effect that can be potentially… Expand
  • figure 1
2015
2015
Among haematological malignancies, Hodgkin’s lymphoma (HL) remains a disease with a high cure rate and overall survival rate of… Expand
  • table 1
  • table 2
Review
2014
Review
2014
The purpose of this review is to summarize the evidence of hepatitis C reactivation in cancer patients in the era of targeted… Expand